Cargando…

Lifestyle treatment in women with polycystic ovary syndrome: predictors of weight loss and dropout

BACKGROUND: Polycystic ovary syndrome (PCOS) affects 5%–10% of women in their reproductive years. Most women with PCOS struggle with obesity during their entire life. Knowing which determinants contribute to a successful lifestyle change is important to optimize treatment options for women with PCOS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiskoot, Geranne, Dietz de Loos, Alexandra, Timman, Reinier, Beerthuizen, Annemerle, Laven, Joop, Busschbach, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304828/ https://www.ncbi.nlm.nih.gov/pubmed/35652323 http://dx.doi.org/10.1002/brb3.2621

Ejemplares similares

Changes in eating behavior through lifestyle treatment in women with polycystic ovary syndrome (PCOS): a randomized controlled trial
por: Jiskoot, Geranne, et al.
Publicado: (2022)

Long-term effects of a three-component lifestyle intervention on emotional well-being in women with Polycystic Ovary Syndrome (PCOS): A secondary analysis of a randomized controlled trial
por: Jiskoot, Geranne, et al.
Publicado: (2020)

Weight Reduction Through a Cognitive Behavioral Therapy Lifestyle Intervention in PCOS: The Primary Outcome of a Randomized Controlled Trial
por: Jiskoot, Geranne, et al.
Publicado: (2020)

Metabolic health during a randomized controlled lifestyle intervention in women with PCOS
por: Dietz de Loos, Alexandra, et al.
Publicado: (2021)

Pregnancy Outcomes in Women with PCOS: Follow-Up Study of a Randomized Controlled Three-Component Lifestyle Intervention
por: Dietz de Loos, Alexandra, et al.
Publicado: (2023)

PMON206 Pregnancy Rate and Outcomes Following a Randomized Controlled Three-component Lifestyle Intervention in Women with PCOS
por: van der Ham, Kim, et al.
Publicado: (2022)

The Effect of Tailored Short Message Service (SMS) on Physical Activity: Results from a Three-Component Randomized Controlled Lifestyle Intervention in Women with PCOS
por: Dietz de Loos, Alexandra, et al.
Publicado: (2023)

A three-component cognitive behavioural lifestyle program for preconceptional weight-loss in women with polycystic ovary syndrome (PCOS): a protocol for a randomized controlled trial
por: Jiskoot, G., et al.
Publicado: (2017)

Translation of the Modified Polycystic Ovary Syndrome Questionnaire (mPCOSQ) and the Polycystic Ovary Syndrome Quality of Life Tool (PCOSQOL) in Dutch and Flemish Women with PCOS
por: Jiskoot, Geranne, et al.
Publicado: (2023)

Sexual Function in Women With Polycystic Ovary Syndrome: Design of an Observational Prospective Multicenter Case Control Study
por: Pastoor, Hester, et al.
Publicado: (2020)

Characteristics of polycystic ovary syndrome throughout life
por: Louwers, Yvonne V., et al.
Publicado: (2020)

Follicle Stimulating Hormone Receptor (FSHR) Polymorphisms and Polycystic Ovary Syndrome (PCOS)
por: Laven, Joop S. E.
Publicado: (2019)

Predictors of Lifestyle Intervention Attrition or Weight Loss Success in Women with Polycystic Ovary Syndrome Who Are Overweight or Obese
por: Moran, Lisa J., et al.
Publicado: (2019)

Bone morphogenetic proteins and the polycystic ovary syndrome
por: van Houten, E Leonie AF, et al.
Publicado: (2013)

Longitudinal Weight Gain and Lifestyle Factors in Women With and Without Polycystic Ovary Syndrome
por: Awoke, Mamaru Ayenew, et al.
Publicado: (2021)

Comparison of 3 Different AMH Assays With AMH Levels and Follicle Count in Women With Polycystic Ovary Syndrome
por: Moolhuijsen, Loes M E, et al.
Publicado: (2022)

Lifestyle and Weight Change in Women With Polycystic Ovary Syndrome During COVID19 Pandemic
por: Eyupoglu, Nesrin Damla, et al.
Publicado: (2021)

Are Dieting and Dietary Inadequacy a Second Hit in the Association with Polycystic Ovary Syndrome Severity?
por: Huijgen, Nicole A., et al.
Publicado: (2015)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome(†)(‡)
por: Teede, Helena J, et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J., et al.
Publicado: (2018)

Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J., et al.
Publicado: (2018)

Polycystic Ovary Syndrome: A Brain Disorder Characterized by Eating Problems Originating during Puberty and Adolescence
por: Steegers-Theunissen, Régine P. M., et al.
Publicado: (2020)

Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment
por: Parker, Jim, et al.
Publicado: (2022)

Erratum. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome
por: Teede, Helena J, et al.
Publicado: (2019)

Barriers and Facilitators to Weight and Lifestyle Management in Women with Polycystic Ovary Syndrome: General Practitioners’ Perspectives
por: Arasu, Alexis, et al.
Publicado: (2019)

Feasibility and acceptability of a proposed trial of acupuncture as an adjunct to lifestyle interventions for weight loss in Polycystic Ovary Syndrome: a qualitative study
por: Ee, Carolyn, et al.
Publicado: (2018)

Predictors of Diet-Induced Weight Loss in Overweight Adults with Type 2 Diabetes
por: Berk, Kirsten A., et al.
Publicado: (2016)

The Effect of Liraglutide on Weight Loss in Women with Polycystic Ovary Syndrome: An Observational Study
por: Rasmussen, Christina B., et al.
Publicado: (2014)

The Genetics of Polycystic Ovary Syndrome: An Overview of Candidate Gene Systematic Reviews and Genome-Wide Association Studies
por: Hiam, Danielle, et al.
Publicado: (2019)

Change in Androgenic Status and Cardiometabolic Profile of Middle-Aged Women with Polycystic Ovary Syndrome
por: van der Ham, Kim, et al.
Publicado: (2023)

The cardiovascular risk profile of middle‐aged women with polycystic ovary syndrome
por: Meun, Cindy, et al.
Publicado: (2019)

Comparison of Lifestyle in Women With Polycystic Ovary Syndrome and Healthy Women
por: Sedighi, Sedigheh, et al.
Publicado: (2015)

Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease
por: Steele, Cortney, et al.
Publicado: (2022)

SF-6D utility values for the better- and worse-seeing eye for health states based on the Snellen equivalent in patients with age-related macular degeneration
por: Visser, Martijn S., et al.
Publicado: (2017)

Predicting Dropouts From an Electronic Health Platform for Lifestyle Interventions: Analysis of Methods and Predictors
por: Pedersen, Daniel Hansen, et al.
Publicado: (2019)

Randomized Controlled Trial of Neurokinin 3 Receptor Antagonist Fezolinetant for Treatment of Polycystic Ovary Syndrome
por: Fraser, Graeme L, et al.
Publicado: (2021)

Dropout, Nonusage Attrition, and Pretreatment Predictors of Nonusage Attrition in a Commercial Web-Based Weight Loss Program
por: Neve, Melinda J, et al.
Publicado: (2010)

Predictors of Dropout by Female Obese Patients Treated with a Group Cognitive Behavioral Therapy to Promote Weight Loss
por: Sawamoto, Ryoko, et al.
Publicado: (2016)

Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: Whose fault is it?
por: Yang, Zhihao, et al.
Publicado: (2017)

Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial
por: Visser, Martijn S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_40829cpld8alc1b2lih6ckv8q8